MX2021005423A - Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos. - Google Patents

Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos.

Info

Publication number
MX2021005423A
MX2021005423A MX2021005423A MX2021005423A MX2021005423A MX 2021005423 A MX2021005423 A MX 2021005423A MX 2021005423 A MX2021005423 A MX 2021005423A MX 2021005423 A MX2021005423 A MX 2021005423A MX 2021005423 A MX2021005423 A MX 2021005423A
Authority
MX
Mexico
Prior art keywords
membered macrolides
macrolides
membered
alkylene substituted
methods
Prior art date
Application number
MX2021005423A
Other languages
English (en)
Spanish (es)
Inventor
Roger B Clark
Andrew G Myers
Peter Niels Carlsen
Richard Alm
Wesley Francis Austin
Philip Hogan
Ivan Jewett
Sushmita D Lahiri
Jonathan F Lawrence
Xiben Li
Shuhao Shi
Wenying Wang
Yoshitaka Ichikawa
Ziyang Zhang
Andre Sanchez
Ganapathy Dhandapani
Thrimurtulu Neetipalli
Md Ataur Rahman
Thomas Lepitre
Original Assignee
Zikani Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68916562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2021005423(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zikani Therapeutics Inc filed Critical Zikani Therapeutics Inc
Publication of MX2021005423A publication Critical patent/MX2021005423A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MX2021005423A 2018-11-19 2019-11-18 Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos. MX2021005423A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862769383P 2018-11-19 2018-11-19
PCT/US2019/062030 WO2020106627A1 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof

Publications (1)

Publication Number Publication Date
MX2021005423A true MX2021005423A (es) 2021-09-08

Family

ID=68916562

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005423A MX2021005423A (es) 2018-11-19 2019-11-18 Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos.

Country Status (19)

Country Link
US (1) US12552825B2 (https=)
EP (2) EP4737470A2 (https=)
JP (2) JP7551610B2 (https=)
KR (1) KR102929869B1 (https=)
CN (1) CN113573779A (https=)
AU (1) AU2019385333B2 (https=)
BR (1) BR112021009624A2 (https=)
CA (1) CA3120148A1 (https=)
DK (1) DK3883647T3 (https=)
ES (1) ES3063764T3 (https=)
FI (1) FI3883647T3 (https=)
IL (1) IL283194B2 (https=)
LT (1) LT3883647T (https=)
MX (1) MX2021005423A (https=)
PT (1) PT3883647T (https=)
SG (1) SG11202105227QA (https=)
SI (1) SI3883647T1 (https=)
SM (1) SMT202600094T1 (https=)
WO (1) WO2020106627A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
CN120152721A (zh) 2022-09-01 2025-06-13 齐卡尼治疗股份有限公司 使用13元大环内酯治疗家族性腺瘤性息肉病

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
NZ526120A (en) * 1999-11-09 2005-02-25 Pfizer Prod Inc 13-membered azalides and their use as antibiotic agents
BR0110382A (pt) * 2000-04-27 2003-06-24 Pfizer Prod Inc Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
WO2003014136A1 (en) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
RU2008106915A (ru) * 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
US20130102551A1 (en) * 2010-07-01 2013-04-25 Andreas Hotte Antibiotic compositions
WO2013004116A1 (zh) * 2011-07-06 2013-01-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) * 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
WO2016154533A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Synthesis of desosamines
US20180273573A1 (en) * 2015-10-01 2018-09-27 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
WO2018201076A2 (en) 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof

Also Published As

Publication number Publication date
SG11202105227QA (en) 2021-06-29
DK3883647T3 (da) 2026-03-23
SI3883647T1 (sl) 2026-04-30
ES3063764T3 (en) 2026-04-20
IL283194A (en) 2021-06-30
IL283194B1 (en) 2024-11-01
PT3883647T (pt) 2026-02-26
EP3883647B1 (en) 2026-02-11
KR20210133950A (ko) 2021-11-08
JP2022507776A (ja) 2022-01-18
EP3883647A1 (en) 2021-09-29
IL283194B2 (en) 2025-03-01
SMT202600094T1 (it) 2026-03-09
US20230093692A1 (en) 2023-03-23
AU2019385333A1 (en) 2021-07-01
CN113573779A (zh) 2021-10-29
US12552825B2 (en) 2026-02-17
KR102929869B1 (ko) 2026-02-23
CA3120148A1 (en) 2020-05-28
AU2019385333B2 (en) 2025-04-17
LT3883647T (lt) 2026-03-25
EP4737470A2 (en) 2026-05-06
JP7551610B2 (ja) 2024-09-17
JP2025000636A (ja) 2025-01-07
FI3883647T3 (fi) 2026-03-25
BR112021009624A2 (pt) 2021-08-10
WO2020106627A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
PH12020500396A1 (en) Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof
AU2018338608A1 (en) Methods, compositions, and implantable elements comprising active cells
EP4520328A3 (en) Heterocyclic compounds as immunomodulators
EP4566675A3 (en) Heterocyclic compounds as immunomodulators
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
MY197635A (en) Benzooxazole derivatives as immunomodulators
PH12016501394A1 (en) Compounds for treating patients with ros1 mutant cancer cells
WO2016198531A3 (en) Hpv vaccines
EP4292650A3 (en) Heterocyclic compounds as immunomodulators
MX2017007814A (es) Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico.
SE1550189A1 (en) Therapeutic and prophylactic composition produced by microbiota
NZ735575A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MX2021005421A (es) Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos.
PH12019502782A1 (en) Fixed dose formulations
MX2016015218A (es) Antibioticos macrociclicos de amplio espectro.
WO2019032936A8 (en) LINCONSAMIDE ANTIBIOTICS AND USES THEREOF
PH12019500083A1 (en) Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
PH12020551905A1 (en) C-mannoside compounds useful for the treatment of urinary tract infections
WO2017024059A8 (en) Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.
MX2021005423A (es) Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos.
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
MX2018006190A (es) Antibioticos de amplio espectro macrociclico.
MX2023005913A (es) Derivados de bencenosulfonamida y usos de los mismos.
MY201377A (en) Compounds and methods for treating bacterial infections